FDA Investigator José E Meléndez
José E Meléndez has inspections in 1 countries as of 28 Mar 2023. José E Meléndez has collaborated with a combined 1139 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
28 Mar 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adalberto Cajigas,
Adaliz Santaliz Cruz,
Angelica M Hernandez,
Ann L Demarco,
Annette Melendez,
Ariel Cruz Figueroa,
Arlene M Badillo,
Arwa S El Hagrasy,
Binh T Nguyen,
Brenda Rivera,
Carlos A Medina,
Carlos Carlos, A Medina,
CDR Ileana Barreto Pettit,
Christina Capacci Daniel, PhD,
Dayna I Martinez,
Dennis Cantellops Paite,
Donna Christner,
Edwin Martinez,
Eva I Merced Medina,
Eva Merced,
German Rivera,
Iraida Ortiz,
Ivis L Negron,
Ivis Lnegron Torres,
Javier O Vega,
Jorge L Guadalupe,
Jose A Cruz,
Jose A Moreno,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Jose E Melendez, DDC,
Jose Perez Soto,
Jose R Lopez,
Jose Velez,
Juan Rjimenez Garcia,
Laiza V Garcia,
Laurimer Kuilan Torres,
Libia M Lugo,
Lisa M Lopez,
Lourdes Andujar,
Marianela Aponte Cruz,
Marybet Lopez,
Michelle Y Clark Stuart,
Miguel A Martinez,
Milva E Melendez,
Min Tang,
Muralidhara B Gavini, PhD,
Myriam M Sosa,
Noreen Muniz,
Noreen Muñiz,
Ramon A Hernandez,
Raquel Gonzalez Rivera,
Rebeca M Melendez,
Rebecca Parrilla,
Rebecca Rodriguez,
Regina T Brown,
Sharmista Chatterjee,
Sonia M Monges,
Steven B Barber,
Thomas J Arista,
Vilmary Negron Rodriguez,
Wanda J Torres
José E Meléndez's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2005 | EIR | CATALENT PR HUMACAO, INC./dba CATALENT PHARMA SOLUTIONS, LLC - EIR, 2005-09-20 |
March, 2010 | FDA 483 Response | Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483R, 2010-04-14 |
December, 2005 | EIR | Wyeth Pharmaceuticals Company - EIR, 2005-12-15 |
March, 2010 | FDA 483 | Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2010-03-31 |
June, 2006 | FDA 483 | INyX USA, Ltd. - Form 483, 2006-06-09 |
May, 2005 | EIR | Janssen Ortho LLC - EIR, 2005-05-23 |
June, 2006 | EIR | INyX USA, Ltd. - EIR, 2006-06-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more